New anticoagulant drugs: a critical perspective.
Haas
Sylvia
S
Institute for Experimental Oncology and Therapy Research, Technical University Munich, Ismaninger Str. 22, 81675 Munich, Germany. sylvia.haas@lrz.tum.de
D000925:Anticoagulants / Q000627:therapeutic use*; D065427:Factor Xa Inhibitors; D006493:Heparin / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D013917:Thrombin / Q000037:antagonists & inhibitors; D013923:Thromboembolism / Q000188:drug therapy
D000925:Anticoagulants; D065427:Factor Xa Inhibitors; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin; D013917:Thrombin